Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement
Swedish Medical Center · University of California, San Francisco · +13 more institutions
Abstract
BACKGROUND AND AIMS: Coronavirus disease 2019 (COVID-19), the illness caused by the SARS-CoV-2 virus, is rapidly spreading throughout the world. Hospitals and healthcare providers are preparing for the anticipated surge in critically ill patients, but few are wholly equipped to manage this new disease. The goals of this document are to provide data on what is currently known about COVID-19, and how it may impact hepatologists and liver transplant providers and their patients. Our aim is to provide a template for the development of clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and healthcare providers. APPROACH AND RESULTS: This article discusses what is…
Citation impact
- FWCI
- 11.30
- Percentile
- 100%
- References
- 49
Authors
15Topics & keywords
- Medicine
- Hepatology
- Coronavirus disease 2019 (COVID-19)
- Pandemic
- 2019-20 coronavirus outbreak
- Statement (logic)
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Family medicine
- Good health and well-being
Funding
- UDU.S. Department of DefenseAwards: 5UL1TR001442, CA170674P2
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- SSanofi
- MGMassachusetts General Hospital
- AAAmerican Association for the Study of Liver Diseases
- GSGilead Sciences
- UOUniversity of Southern California
- APAlnylam Pharmaceuticals
- CCelgene
- UOUniversity of Pennsylvania
- NUNorthwestern University
- CCCincinnati Children's Hospital Medical Center
- UOUniversity of Minnesota
- APArrowhead Pharmaceuticals
- GGrifols
- ETEsperion Therapeutics
- AAllergan
- UOUniversity of North Carolina at Chapel Hill
- NINational Institute of Diabetes and Digestive and Kidney DiseasesAwards: P30DK120515, 1R01DK121378, R01DK106419
- NINational Institute of Environmental Health SciencesAward: 5P42ES010337
- NCNational Center for Advancing Translational SciencesAwards: P30DK120515, 5UL1TR001442, R01DK106419
- DPDOD Peer Reviewed Cancer Research Program